New York — A new study suggests that the use of autologous platelet-rich fibrin matrix (PRFM) yields good results in facial plastic surgery procedures, Reuters Health reports.
Study author Anthony Sclafani, M.D., director of facial plastic surgery at the New York Eye and Ear Infirmary, conducted a chart review of 50 patients who had undergone aesthetic facial procedures with autologous PRFM. The most common indications for treatment were nasolabial folds, facial volumization, superficial wrinkles and acne scars.
According to Dr. Sclafani, most patients were satisfied with the treatments and noted improvement within seven days. Five of the patients were dissatisfied with their results and underwent a second PRFM treatment. One of these patients remained dissatisfied with results following the second PRFM procedure.
In his study, published online Feb. 21 in Archives of Facial Plastic Surgery, Dr. Sclafani writes, “Autologous tissue would be the ideal material choice for soft-tissue augmentation in the face if it could be provided in a simple process with good predictability.”
Dr. Sclafani is a consultant for and has received research support from Aesthetic Factors, maker of the PRFM used in his study.